R. S. Gelman
- Oncology top 10%
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- William SilenJames L. ConnollyStuart J. SchnittMary Ann RoseAbram RechtJay R. HarrisEric P. WinerNadine Tung
- Topics
- Cancer Treatment and Pharmacology (10 papers)Breast Cancer Treatment Studies (6 papers)Lung Cancer Treatments and Mutations (5 papers)
- Partner nations
- United States
In The Last Decade
R. S. Gelman
17 papers receiving 496 citations
Peers
Comparison fields: 5 of 51
- Oncology 363
- Cancer Research 306
- Pathology and Forensic Medicine 139
- Pulmonary and Respiratory Medicine 98
- Molecular Biology 89
Countries citing papers authored by R. S. Gelman
This map shows the geographic impact of R. S. Gelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. S. Gelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. S. Gelman more than expected).
Fields of papers citing papers by R. S. Gelman
This network shows the impact of papers produced by R. S. Gelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. S. Gelman. The network helps show where R. S. Gelman may publish in the future.
Co-authorship network of co-authors of R. S. Gelman
This figure shows the co-authorship network connecting the top 25 collaborators of R. S. Gelman. A scholar is included among the top collaborators of R. S. Gelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. S. Gelman. R. S. Gelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 122 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 71 | |
| 8 | 1 | |
| 9 | 23 | |
| 10 | 10 | |
| 11 | Uses of CD4-lymphocyte count in AIDS treatment decisions. | 6 |
| 12 | 20 | |
| 13 | 180 | |
| 14 | 20 | |
| 15 | Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue. | 23 |
| 16 | Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer. | 7 |
| 17 | Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment. | 10 |
About R. S. Gelman
R. S. Gelman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 521 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Cancer Research (306 citations), Oncology (363 citations) and Pathology and Forensic Medicine (139 citations). R. S. Gelman has collaborated with scholars based in United States. Frequent co-authors include William Silen, James L. Connolly, Stuart J. Schnitt, Mary Ann Rose, Abram Recht, Jay R. Harris, Eric P. Winer, Nadine Tung, SJ Isakoff and Vincent L. Giranda. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.